WHO Approves Haemophilia Health Equity Resolution
Analysis based on 9 articles · First reported Feb 10, 2026 · Last updated Feb 10, 2026
The approval of this resolution by the World Health Organization's Executive Board is a positive development for the healthcare industry, particularly for companies involved in treatments for Haemophilia and other bleeding disorders. It signals a global commitment to addressing these conditions, potentially leading to increased research, development, and access to care.
On February 3, 2026, the Executive Board of the World Health Organization approved a Member-State led resolution on Global Action to Advance Health Equity for People with Haemophilia and Other Bleeding Disorders. This resolution will be presented at the 79th World Health Assembly in May 2026 for final adoption. The World Federation of Hemophilia, a non-state actor in official relations with the World Health Organization, has been a strong advocate for this resolution. Its adoption will recognize bleeding disorders as a priority and lead to a coordinated global framework and concrete actions to address health inequities.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard